Pacific Islander, Māori, and African American populations demonstrate both elevated baseline hyperuricemia and greater obesity-attributable gout risk compared to white populations, likely reflecting genetic variants in urate transporters (ABCG2, SLC2A9) interacting with metabolic factors [47]. The gene discussed is SLC2A9; the disease is Obesity.